Selank Nasal 10 mg — analytical-grade research peptideSelank Nasal Spray · 10 mg / pre-filled spray
Fig. 01 · Specimen
Nasal spray
In the box
  • ·Pre-filled nasal-spray bottle (10 mg active)
NootropicClass ISelank Nasal Spray

Selank Nasal 10 mg

Selank in nasal-spray formulation.

Pre-filled nasal-spray format of Selank — matches the Russian clinical intranasal route.

Designation
Selank Nasal Spray
CAS no.
129954-34-3
Molecular formula
C33H57N11O9
MW (Da)
751.87
Residues
7
Purity
≥ 99.0%
Form
Nasal spray
Dose
10 mg / pre-filled spray
Class
Class I
Dispatch · per unit
£59GBP
≈ €70 · 0.00109 BTC
1
In stock·Same-day dispatch (order by 09:30 UK)·Tracked24 Royal Mail £6.50·Not shipped to USA
Clinical status: Nasal spray matches the Russian clinical delivery route. Research use only outside Russia.
§ A Overview

What the peptide is.

Nasal-spray formulation of Selank.

Proposed mechanism

As per Selank 11 mg.

§ B Laboratory handling

Reconstitution, storage, and handling.

Lab-technical guidance for the researcher handling the material. Not therapeutic dosing, not administration guidance — those are not within the scope of this supply.

Reconstitution
Recommended solvent
Pre-reconstituted
Typical volume
N/A
Notes
    Storage
    Lyophilised
    2–8 °C, upright, sealed.
    Reconstituted
    Same as sealed — pre-formulated.
    Shelf life · sealed
    18 months refrigerated.
    Shelf life · reconstituted
    Per label.
    Handling notes
    • Upright storage.
    § C Certificate of Analysis

    This lot, documented.

    Every shipment is accompanied by a signed four-page analytical report including the HPLC chromatogram, ESI-MS spectrum, purity calculation, and sample handling chain-of-custody.

    The report you will receive is specific to the lot dispatched to you. The display below is a current representative example.

    selank nasal 10mg · batch.log
    LIVE
    04:22:11lot 26-04-A received ┈ 5.00 g
    04:22:40weight check ┈ PASS ±0.4 mg
    04:23:12sample → janoshik ┈ 50 mg
    04:23:12tracking #jnk-9218334
    05:18:03HPLC result ┈ 99.24 %
    05:18:04MS obs 4729.42 Da ┈ PASS
    05:18:05coa.pdf signed ┈ attached
    05:18:06lot approved ┈ LIVE
    janoshik.report.txt
    SIGNED
    REPORT ID     JA-26-04-012
    SUBJECT       Selank Nasal 10 mg
    DESIGNATION   Selank Nasal Spray
    LOT           26-04-A
    METHOD        RP-HPLC, ESI-MS
    COLUMN        C18, 250 x 4.6 mm, 5 um
    MOBILE PHASE  A: 0.1% TFA in H2O
                  B: 0.1% TFA in ACN
    GRADIENT      5 -> 65% B over 20 min
    FLOW RATE     1.0 mL/min
    DETECTION     UV 214 nm
    INJECTION     20 uL @ 0.5 mg/mL
    ---
    PURITY (A%)   99.00
    MASS EXP.     751.87 Da
    MASS OBS.     751.89 Da
    ---
    CONCLUSION    Identity CONFIRMED · Purity PASS
    SIGNED BY     J. Novak, MSc · Janoshik Analytical SVK
    DATE          2026-04-11
    representative chromatogram · A214 nmRT 8.42 min
    Representative trace · Lot-specific COA included with every dispatch
    purity≥ 99.0%
    § E Peer-reviewed studies

    Research references for Selank Nasal 10 mg.

    0 peer-reviewed publications. Links resolve to PubMed. DOIs are provided where available.

      § F Questions

      About this peptide.

      For general site, shipping, and payment questions see the full FAQ.

      Research use only

      This peptide is supplied by Omega Grade for in vitro laboratory research use. It is not a drug, food, cosmetic, or dietary supplement. It is not approved by the FDA, EMA, MHRA, PMDA, or any other regulatory authority for any therapeutic indication.

      No claim of therapeutic benefit is made or implied. The material is not intended for human or veterinary consumption, administration, or any form of self-experimentation. By purchasing, you acknowledge the researcher terms and accept full responsibility for local import compliance and all handling.